How scientists in Fort Worth raced to identify Hill Country flood victims

Scientists at the Center for Human Identification at UNT Health worked around the clock after the Hill Country floods to ...
TMCnet

InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow™ Ovarian Cancer Diagnostic Test

InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions, and Aranscia, a global provider of award-winning ...

Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial

Data presented during ICCBH 2026 showed that improvements in tibial-femoral angle (TFA), a measure of lower extremity alignment, continued ...
IMAGE MagazineOpinion

Blepharoplasties: ‘No little girl grows up dreaming about having her eyelids cut off’

As surgically altered faces become the new normal, it is worth asking who benefits from convincing women that even their ...
New Scientist

I’m the first person whose life was saved by CRISPR base editing

When standard leukaemia treatments failed, 13-year-old Alyssa Tapley was told she had only weeks left – but then she was ...
Scientific American

How CRISPR could target the body’s epigenome—the software that controls our genes

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

Scientists cured sickle cell. Then their next challenge began.

Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these ...
AlphaGalileo

The ANERIS project holds its Final Consortium Meeting in Spain

The ANERIS project has held its Final Consortium Meeting in person, bringing together all project partners for a two-day ...